Anaphylaxis is a serious immediate allergic reaction that involves the activation of mast cells. Cross-linking of the high-affinity IgE receptor FcεRI on mast cells with IgE and antigen initiates signals leading to the release of allergic mediators that induce immediate hypersensitivity 1 . Anaphylaxis is triggered by allergens (for example, insect venom, food and medication) and damages multiple organs including the respiratory and circulatory systems, often leading to life-threatening episodes.
A r t i c l e s
Anaphylaxis is a serious immediate allergic reaction that involves the activation of mast cells. Cross-linking of the high-affinity IgE receptor FcεRI on mast cells with IgE and antigen initiates signals leading to the release of allergic mediators that induce immediate hypersensitivity 1 . Anaphylaxis is triggered by allergens (for example, insect venom, food and medication) and damages multiple organs including the respiratory and circulatory systems, often leading to life-threatening episodes.
Environmentally induced alterations in phenotypes of mast cells could be one factor that influences the severity of anaphylaxis. Current evidence has established the essential role of stem cell factor (SCF) and its receptor c-Kit (CD117) for development of mast cells 2 . However, the SCF-c-Kit system alone is insufficient to drive the maturation of mast cells fully, as culture of immature mast cells with fibroblasts, but not with SCF alone, can induce differentiation into mature mast cells 2 . Although several cytokines, chemokines and adhesion molecules have supporting roles in tissue-specific homing, growth or differentiation of mast cells [3] [4] [5] [6] [7] , precise mechanisms underlying mast cell-fibroblast communication leading to optimal maturation of mast cells still remain elusive.
Lipid mediators, such as prostaglandins, leukotrienes and lysophospholipids, have important roles in various biological processes, including allergy [8] [9] [10] [11] [12] [13] [14] [15] . A given lipid mediator (for example, PGD 2 ) aggravates, suppresses or resolves allergic responses [11] [12] [13] , and this functional variability may depend on the use of distinct biosynthetic enzyme and/or receptor subtypes in different cells. Eicosanoid biosynthesis is initiated by release of arachidonic acid from phospholipids by phospholipase A 2 (PLA 2 ) enzymes 16 . PLA2G4A (cytosolic PLA 2 ; cPLA 2 α) has an essential role in the generation of eicosanoids in various cells, and its deletion results in diminished airway hypersensitivity 17 .
By contrast, the role of secreted PLA 2 (sPLA 2 ) enzymes is still a subject of debate. Although the lower asthmatic responses in mice lacking two classical sPLA 2 enzymes (PLA2G5 and PLA2G10) have revealed their contribution to asthma 18, 19 , the mechanisms underlying the actions of these enzymes remain poorly understood.
A major bee venom component responsible for anaphylaxis is an atypical form of sPLA 2 called BV-PLA 2 20,21 . The mammalian genome encodes group III sPLA 2 (PLA2G3), which is the sole homolog of BV-PLA 2 16,22-26 . Here we provide evidence that PLA2G3 is a major mast cell granule-associated sPLA 2 that facilitates the maturation of mast cells by driving a previously unrecognized lipid mediator circuit. PLA2G3 released from mast cells is coupled with fibroblast lipocalin-type PGD synthase (L-PGDS) to provide PGD 2 , which then acts on type-1 PGD receptor, DP1, induced on mast cells to promote their maturation.
RESULTS

PLA2G3 is expressed in mast cells and induces their activation
When injected intradermally into the mouse ear pinnas, BV-PLA 2 or human PLA2G3 alone induced a similar, dose-dependent vascular leak and augmented passive cutaneous anaphylaxis (PCA) induced by IgE and antigen in Kit +/+ mice but not in mast cell-deficient Kit W−sh/W−sh mice, in which the SCF receptor c-Kit has a substitution (Fig. 1a,b) . The edema induced by PLA2G3 was accompanied by ultrastructural degranulation of dermal mast cells (Fig. 1c) . PLA2G3 induced the release of histamine (Fig. 1d) , but not of lactate dehydrogenase ( Supplementary Fig. 1a) , from mouse peritoneal mast cells (pMCs) in a Ca 2+ -dependent manner, indicating that PLA2G3 elicits degranulation, not cell lysis.
Immunohistochemistry analysis revealed that PLA2G3 localized with toluidine blue + dermal mast cells in wild-type mice but not in Pla2g3 −/− mice 22 (Fig. 1e) . Punctate staining in resting mast cells and sparse staining in degranulated mast cells suggest that PLA2G3 is released upon degranulation (Fig. 1e,f) . In bone marrow-derived cell populations, Pla2g3 mRNA was more highly enriched in IL-3-driven bone marrow-derived mast cells (BMMCs) and thymic stromal lymphopoietin (TSLP)-driven bone marrow-derived basophils (BM basophils) than in GM-CSF-driven bone marrow-derived dendritic cells (BMDCs) and M-CSF-driven bone marrow-derived macrophages (BMDMs), and was undetectable in Swiss 3T3 fibroblasts ( Fig. 1g and Supplementary Fig. 1b) . Of the mRNAs encoding sPLA 2 isoforms, Pla2g3 mRNA was expressed most abundantly in BMMCs, followed by Pla2g5 and Pla2g2e, whereas mRNAs encoding the other sPLA 2 isoforms were undetectable, and SCF-fibroblast-driven maturation of these cells toward connective tissue mast cells (CTMCs) did not affect the expression of these sPLA 2 enzymes ( Supplementary  Fig. 1c ). When we transfected rat mastocytoma RBL-2H3 cells with cDNA encoding PLA2G3 or a catalytically inactive PLA2G3 variant, III-HQ, in which the catalytic-center histidine was replaced with asparagine 23 , release of β-hexosaminidase (β-HEX) and generation of PGD 2 induced by crosslinking of FcεRI by IgE and antigen (hereafter called IgE-Ag) was augmented in cells overexpressing native PLA2G3 but not catalytically inactive PLA2G3 (Supplementary Fig. 1d ). Thus, PLA2G3 is the main sPLA 2 in mouse mast cells, is released by exocytosis and can augment activation of mast cells in a manner dependent upon its enzymatic activity.
Pla2g3 deletion ameliorates mast cell-associated anaphylaxis Upon passive systemic anaphylaxis (PSA) induced by IgE-Ag, Pla2g3 +/+ and WBB6F1-Kit +/+ mice, but not mast cell-deficient WBB6F1-Kit W/W−v mice, had much more plasma histamine and a temporary decrease in rectal temperature after systemic antigen challenge, whereas these responses were mild in Pla2g3 −/− mice (Fig. 2a) . Upon PCA induced by IgE-Ag ( Fig. 2b and Supplementary Fig. 1e ) or compound 48/80 (C48/80; Fig. 2c) , edema was markedly lower in Pla2g3 −/− mice than Pla2g3 +/+ mice. By contrast, transgenic overexpression of human 
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A r t i c l e s PLA2G3 (PLA2G3 tg/+ ) 26 augmented both IgE-Ag-dependent ( Fig. 2d and Supplementary Fig. 1e ) and C48/80-induced (Fig. 2e) PCA as well as IgE-Ag-induced PSA (Fig. 2f) . Although the ear skin of Pla2g3 −/− and Pla2g3 +/+ mice contained an equivalent number of toluidine blue + mast cells, we detected fewer cells showing signs of IgE-Ag-induced degranulation in Pla2g3 −/− mice than in Pla2g3 +/+ mice (Fig. 2g) . Conversely, ears of IgE-Ag-treated PLA2G3 tg/+ mice had more degranulated mast cells than those of replicate control mice despite a similar total mast cell count (Fig. 2h) Fig. 1f ).
We immunized Pla2g3 +/+ and Pla2g3 −/− mice intraperitoneally with alum-adsorbed ovalbumin (OVA) and elicited active cutaneous anaphylaxis by intradermal injection of OVA, which cross-links endogenous IgE-bound FcεRI on mast cells. Under conditions in which serum anti-OVA IgE levels were similar in both genotypes, Pla2g3 −/− mice exhibited lower local anaphylaxis than did Pla2g3 +/+ mice, as indicated by notable reductions in ear swelling and mast cell degranulation ( Fig. 2i-k) . Thus, PLA2G3 is the sole sPLA 2 isoform associated with mast cell-dependent anaphylaxis.
Pla2g3 deletion impairs maturation of tissue mast cells
Transmission electron microscopy analysis revealed that resting mast cells in Pla2g3 +/+ mice were oval with regular short processes and had many secretory granules filled with electron-lucent and dense contents, whereas those in Pla2g3 −/− mice had unusual granules that were small and irregular in size, suggesting the Data are from one experiment (f-i,k) and compiled from three experiments (a-e,j) (mean ± s.e.m., *P < 0.05; **P < 0.01; NS, not significant).
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A r t i c l e s immaturity of mast cells ( Fig. 3a and Supplementary Fig. 2a ). After challenge with antigen, Pla2g3 +/+ skin mast cells exhibited features typical of degranulation, whereas Pla2g3 −/− mast cells were almost insensitive. In agreement, the amount of histamine (Fig. 3b ) and the expression of Hdc (which encodes histidine decarboxylase, a histamine-biosynthetic enzyme; Fig. 3c ) were lower in the ears of Pla2g3 −/− mice than in those of Pla2g3 +/+ mice. Enzymatic activity ( Fig. 3d) and expression ( Fig. 3e) of mast cell proteases, including chymase (encoded by Mcpt4), tryptase (encoded by Mcpt6) and carboxypeptidase (encoded by Cpa3), were also notably lower in the ears of Pla2g3 −/− mice relative to Pla2g3 +/+ mice. However, expression of Kit, Mitf (which encodes a transcription factor essential for mast cell differentiation) and Srgn (which encodes serglycin, a proteoglycan core protein) was unchanged in ears of Pla2g3 −/− mice ( Fig. 3e) , indicating that not all mast cell markers were affected by PLA2G3 deficiency. We confirmed the lower expression of HDC and the unaltered expression of c-Kit in the skin of Pla2g3 −/− mice by immunoblotting (Fig. 3f) .
Pla2g3 −/− pMCs also had smaller and more irregular granules ( Fig. 3g and Supplementary Fig. 2b ), contained less histamine ( Fig. 3h) and exhibited less IgE-Ag-induced histamine release (both amount and percentage; Fig. 3i ) than Pla2g3 +/+ pMCs. Although the proportion of Kit + FcεRIα + skin mast cells or pMCs was similar in both genotypes, surface expression of FcεRIα was lower in Pla2g3 −/− mice than in Pla2g3 +/+ mice ( Supplementary Fig. 2c,d ). A23187-induced histamine release by Pla2g3 −/− pMCs was lower in terms of amount, but not percentage, compared to that by Pla2g3 +/+ pMCs ( Supplementary Fig. 2e ), suggesting that the attenuated IgE-Ag-induced degranulation and anaphylaxis in Pla2g3 −/− mice was mainly due to the lower histamine content and surface Fig. 2f) . Thus, the lower anaphylaxis in Pla2g3 −/− mice may result from abnormalities in the maturation and degranulation of mast cells in multiple anatomical sites. Other immune-cell populations in the skin and spleen were unaffected by PLA2G3 deficiency (Supplementary Fig. 2g,h) .
To assess whether the aberrant features of mast cells in Pla2g3 −/− mice relied on the absence of PLA2G3 in the mast cells themselves or in mast cell microenvironment, we transferred Pla2g3 +/+ or Pla2g3 −/− BMMCs intradermally into mast cell-deficient Kit W−sh/W−sh mice. After 6 weeks, the distribution of mast cells in the ear dermis was comparable between mice reconstituted with Pla2g3 +/+ BMMCs and those reconstituted with Pla2g3 −/− BMMCs (Supplementary Fig. 3a) . Expression of mast-cell marker genes Hdc, Mcpt4, Mcpt6 and Cpa3 (Fig. 3j) and IgE-Ag-mediated PCA ( Fig. 3k and Supplementary  Fig. 3b) Fig. 3c,d ). In these experiments, low levels of mast-cell engraftment in the skin of Kit W−sh/W−sh mice relative to baseline amounts in the skin of wildtype mice restored PCA efficiently. Kit W−sh/W−sh mice transferred with PLA2G3 tg/+ BMMCs had a greater PCA response compared to those transferred with control BMMCs (Supplementary Fig. 3e) . Altogether, the defective maturation and activation of mast cells in Pla2g3 −/− mice are cell autonomous, even though the migration of mast cell progenitors into extravasuclar tissues is not profoundly impaired by PLA2G3 deficiency. Fig. 4a ) and, unlike tissue-resident mast cells, they had normal surface expression of FcεRIα ( Supplementary  Fig. 4b ). Stimulation with IgE-Ag induced a robust release of sPLA 2 activity from wild-type BMMCs, whereas this release was ablated in Pla2g3 −/− BMMCs and augmented in PLA2G3 tg/+ BMMCs ( Supplementary Fig. 4c,d) , confirming that PLA2G3 is released upon degranulation. IgE-Ag-stimulated Pla2g3 −/− BMMCs released less histamine, PGD 2 and LTC 4 than Pla2g3 +/+ BMMCs, whereas these responses were greater in PLA2G3 tg/+ BMMCs than in control BMMCs (Supplementary Fig. 4e-j) . IgE-Ag-induced influx of Ca 2+ , induction of cytokines (encoded by Il4, Il6 and Tnf) and phosphorylation of phospholipase C (PLCγ2) and Akt were similar between the genotypes (Supplementary Fig. 4k-m) , suggesting that FcεRI-dependent signaling was not profoundly perturbed by PLA2G3 deficiency. Generation of eicosanoids by mast cells depends on cPLA 2 α, which is regulated by Ca 2+ -dependent membrane translocation and MAP kinase-directed phosphorylation 17 . Consistent with the lower generation of eicosanoids (Supplementary Fig. 4f,g ), FcεRI-dependent phosphorylation of ERK (not JNK and p38) and cPLA 2 α and decrease in arachidonic acid-containing phosphatidylcholine were partially impaired in Pla2g3 −/− BMMCs compared to Pla2g3 +/+ BMMCs, despite the equivalent expression of total ERK and cPLA 2 α proteins in both cells (Supplementary Fig. 4m-o) . Thus, PLA2G3 deficiency attenuates activation of ERK and cPLA 2 α in BMMCs.
We took advantage of an in vitro system in which immature BMMCs undergo maturation toward mature CTMC-like cells in coculture with Swiss 3T3 fibroblasts 27 . PLA2G3 deficiency did not affect the proliferation of BMMCs in coculture ( Supplementary  Fig. 5a ). During coculture, sPLA 2 activity was secreted from wild-type BMMCs in response to SCF, whereas sPLA 2 secretion was absent in Pla2g3 −/− BMMCs and augmented in PLA2G3 tg/+ BMMCs (Fig. 4a,b) . Although the ultrastructure of Pla2g3 −/− BMMCs appeared normal, Pla2g3 −/− CTMC-like cells contained unusual granules with less electron-dense contents than did Pla2g3 +/+ CTMC-like cells (Fig. 4c  and Supplementary Fig. 5b ). After coculture, the expression of Hdc (Fig. 4d) and its product histamine (Fig. 4e) were markedly greater in Pla2g3 +/+ CTMC-like cells, whereas these changes were barely seen in Pla2g3 −/− cells. Even before coculture, Hdc expression and histamine content were slightly lower in Pla2g3 −/− BMMCs than in Pla2g3 +/+ BMMCs, indicating that some early developmental process had already been perturbed by PLA2G3 deficiency. IgE-Ag-induced histamine release was greater in Pla2g3 +/+ cells after coculture than before coculture, whereas this coculture-driven increase in histamine release was impaired in Pla2g3 −/− cells (Fig. 4f) . Conversely, cocultureinduced Hdc expression was greater in PLA2G3 tg/+ CTMC-like cells than in control cells (Supplementary Fig. 5c ). Supplementation with PLA2G3 in coculture significantly restored the histamine level in Pla2g3 −/− CTMC-like cells and also elevated it in Pla2g3 +/+ cells (Fig. 4g) . Pla2g3 −/− BMMCs without coculture did not respond to PLA2G3 (Fig. 4g) , suggesting that the action of PLA2G3 on histamine synthesis in mast cells depends on fibroblasts. Histamine content in Pla2g3 +/+ BMMCs without coculture was substantially lower in the presence of PLA2G3 than its absence (Fig. 4g) , which might reflect that the enzyme elicits the release of prestored histamine by degranulation (Fig. 1b) .
The maturation of wild-type BMMCs to CTMC-like cells increased FcεRI-dependent PGD 2 synthesis (Fig. 4h) , with a concomitant increase in Ptgds2 (hematopoietic PGD 2 synthase; H-PGDS) (Fig. 4i) . However, these changes in the PGD 2 pathway occurred only weakly in Pla2g3 −/− cells. Surface expression of FcεRIα was significantly elevated in Pla2g3 +/+ cells but not in Pla2g3 −/− cells after coculture (Supplementary Fig. 5d) , consistent with the lower surface FcεRIα expression on tissue-resident mast cells in Pla2g3 −/− mice. The coculture-driven induction of Mcpt4 and Mcpt6 (which encode mast cell proteases) and Ndrg1 (which encodes a mast cell granule-associated protein 27 ) was also impaired in Pla2g3 −/− cells, whereas the constitutive expression of Srgn and Kit was unaffected (Supplementary Fig. 5e ). We verified the attenuated induction of HDC and H-PGDS and the unaltered expression of c-Kit in Pla2g3 −/− CTMC-like cells at the protein level (Fig. 4j) . Although Pla2g3 +/+ CTMC-like cells acquired sensitivity to C48/80 after coculture 27 , C48/80-induced degranulation (Fig. 4k) and induction of the putative C48/80 receptors encoded by Mrgprx1 and Mrgprx2 (ref. 28; Supplementary Fig. 5e ) after coculture were lower in Pla2g3 −/− cells. The coculture-dependent decrease in Itga5 (which encodes integrin α E ) and increase in Icam1 (which encodes integrin β 7 ), which participates in tissue homing of mast-cell progenitors 6 , were unaffected by PLA2G3 deficiency (Supplementary Fig. 5e) , consistent with the unaltered number of mast cells in Pla2g3 −/− tissues. Microarray gene profiling using Pla2g3 +/+ and Pla2g3 −/− BMMCs before and after coculture revealed that, of the ~41,000 genes examined, Pla2g3 +/+ cells expressed 3,632 coculture-inducible genes, of which 1,409 genes were barely or only partially induced in Pla2g3 −/− cells. Genes affected by Pla2g3 ablation included, for example, genes associated with secretory granules, genes related to biosynthesis or receptors for lipid mediators, npg and genes for cytokines, chemokines and their receptors (Fig. 4l and  Supplementary Table 1) , underscoring the immaturity of Pla2g3 −/− cells, particularly after coculture.
By comparison, Pla2g4a −/− mice exhibited normal IgE-Ag-induced PCA, with normal counts of dermal mast cells and normal amounts of histamine (Supplementary Fig. 5f-h) . IgE-Ag-induced histamine release, cellular histamine content and Hdc expression were unaffected by ablation of cPLA 2 α (Supplementary Fig. 5i-k) . Neither PGD 2 nor LTC 4 was produced by Pla2g4a −/− BMMCs (Supplementary Fig.  5l,m) , confirming the obligatory role of cPLA 2 α in eicosanoid synthesis in mast cells 29 . Thus, the absence of mast cell-derived eicosanoids by cPLA 2 α deficiency did not affect maturation, degranulation and anaphylaxis of mast cells, suggesting that the effect of PLA2G3 deficiency on mast cells could not be simply explained by defective synthesis of eicosanoids by mast cells.
PGD 2 -DP1 signals mast-cell maturation downstream of PLA2G3
To identify the specific lipid-mediator pathway that lies downstream of PLA2G3, we induced IgE-Ag-dependent PCA on mouse lines deficient in various eicosanoid receptors or biosynthetic enzymes. Of the eicosanoid receptor-deficient mouse lines tested, PCA was lower only in mice lacking the PGD receptor DP1 (Ptgdr −/− ) 9 . Vascular leakage was lower and ear mast cells exhibited poor degranulation despite an unaltered total count in Ptgdr −/− mice compared to wild-type mice (Fig. 5a,b) . Dermal mast cells in Ptgdr −/− mice had fewer mature secretory granules, contained less histamine and were less sensitive to IgE-Ag-induced degranulation than those in Ptgdr +/+ mice (Fig. 5c,d) . Whereas the PCA was efficiently restored in Kit W−sh/W−sh mice reconstituted with Ptgdr +/+ BMMCs, it was restored only partially in those mice reconstituted with Ptgdr −/− BMMCs (Fig. 5e) Fig. 6a ).
Although Ltc4s −/− mice exhibited a lower PCA response as reported 10 , their ear histamine content was unaffected (data not shown). Thus, abnormalities in mast cells observed in mice lacking PLA2G3 were phenocopied only in mice lacking DP1. Next we examined the expression and function of DP1 in a mast cell-fibroblast coculture system 27 . Although we barely detected Ptgdr mRNA in BMMCs and Swiss 3T3 fibroblasts, Ptgdr mRNA was robustly induced in Pla2g3 +/+ , but not in Pla2g3 −/− , CTMC-like cells after coculture (Fig. 5f) . Consistently, Ptgdr expression in the ear was lower in Pla2g3 −/− mice than in Pla2g3 +/+ mice (Fig. 5g) . In agreement with the lower histamine amount in Ptgdr −/− dermal mast cells (Fig. 5d) , the coculture-driven Hdc induction was severely impaired in Ptgdr −/− CTMC-like cells (Fig. 5h) . In addition, the DP1 antagonist BW A868C prevented the coculture-induced upregulation of Hdc in wild-type CTMC-like cells (Fig. 5i) . Conversely, the DP1 agonist BW 245C significantly enhanced Hdc induction in wild-type CTMC-like cells (Fig. 5j) . However, the coculture-driven Hdc expression was barely restored by BW 245C in Pla2g3 −/− mice (Fig. 5j) , likely because DP1 induction was blunted by PLA2G3 deficiency (Fig. 5f) . To circumvent this problem, we used the cAMP-elevating agent forskolin because DP1 is coupled with Gs-cAMP signaling 9 . The addition of forskolin to the coculture bypassed the requirement for DP1 in the induction of Hdc in Pla2g3 −/− CTMC-like cells (Fig. 5k) . By comparison, the expression of Ptgdr2, which encodes another PGD 2 receptor known as CRTH2, was high in BMMCs and lowered in accordance with their maturation into CTMC-like cells, without being affected by the Pla2g3 genotypes (Supplementary Fig. 6b) . Moreover, Hdc induction in CTMC-like cells was unaffected by CRTH2 deficiency in coculture, and Ptgdr2 expression was unaffected by PLA2G3 deficiency in vivo (Supplementary Fig. 6c,d) . The coculture-driven production of other eicosanoids such as 15-HETE and PGI 2 was unaffected by PLA2G3 deficiency (Supplementary Fig. 6e) . Thus, DP1-cAMP signaling is specifically required for the PLA2G3-dependent maturation of mast cells.
L-PGDS supplies a PGD 2 pool for mast-cell maturation
We hypothesized that the absence of PGD 2 biosynthetic enzyme(s), acting downstream of PLA2G3 and upstream of DP1, would also influence maturation of mast cells. Of the two PGD 2 synthaseencoding genes, Ptgds2 (which encodes H-PGDS) was expressed in BMMCs but not in Swiss 3T3 fibroblasts, whereas Ptgds (which encodes lipocalin-type PGDS; L-PGDS) expression was higher in fibroblasts than in BMMCs (Fig. 6a) and was below the detection limit in pMCs (data not shown). L-PGDS immunoreactivity was associated with fibroblasts surrounding toluidine blue + mast cells in mouse skin (Supplementary Fig. 7a) . PCA was exacerbated in Ptgds2 −/− mice 30 , which lack H-PGDS (Fig. 6b) , whereas it was suppressed in Ptgds −/− mice 31 , which lack L-PGDS (Fig. 6c) , in comparison with respective control mice. Ptgds −/− mice had fewer degranulated ear mast cells than did Ptgds +/+ mice after antigen challenge, although the total mast cell count was unaffected (Fig. 6d) . Dermal mast cells in Ptgds −/− mice were ultrastructurally immature (that is, cytoplasmic granules were small and heterogeneous), comparatively resistant to antigen-induced degranulation, and contained less histamine than those in Ptgds +/+ mice (Fig. 6e,f) . Thus, the notable similarity among Fig. 7b) , and a similar induction of Hdc occurred when Ptgds +/+ or Ptgds −/− BMMCs were cultured with fibroblasts (Supplementary Fig. 7c ), indicating that L-PGDS in fibroblasts, not in mast cells, may be important for the regulation of mast cells.
Coculture with L-PGDS-silenced Swiss 3T3 fibroblasts by two distinct Ptgds-specific small interfering (si)RNAs resulted in less induction of Hdc in wild-type CTMC-like cells (Fig. 6g) . PGD 2 generation after coculture of parent fibroblasts with Pla2g3 −/− BMMCs was ~50% lower than with Pla2g3 +/+ BMMCs (Fig. 6h) . The L-PGDS inhibitor AT-56 lowered PGD 2 generation and Hdc induction in Pla2g3 +/+ cocultures to amounts similar to those in Pla2g3 −/− cocultures, although it did not affect these responses in Pla2g3 −/− cocultures (Fig. 6h,i and Supplementary Fig. 7d) . Hdc induction in wild-type BMMCs also occurred in coculture with primary skin fibroblasts from Ptgds +/+ mice, whereas this response was impaired in coculture with those from Ptgds −/− mice (Fig. 6j) . Thus, the augmentative effects of PLA2G3 on coculture-driven synthesis of PGD 2 and histamine were abrogated when L-PGDS in fibroblasts was ablated. L-PGDS-dependent production of PGD 2 , as revealed by coculture of Ptgds2 −/− BMMCs with Swiss 3T3 fibroblasts, occurred gradually over a long period, whereas H-PGDS-dependent production of PGD 2 was transient, albeit robust (Supplementary Fig. 7e) , suggesting that the continuous supply of PGD 2 by L-PGDS is crucial for maturation of mast cells.
Additionally, we observed robust upregulation of Ptgds2 in BMMCs and Ptgds in Swiss 3T3 fibroblasts or in primary mouse skin fibroblasts (and to a much lesser extent in BMMCs) in wildtype BMMC cocultures, whereas these responses occurred only partially in Pla2g3 −/− BMMC cocultures (Supplementary Fig. 7f-h) . Conversely, induction of Ptgds in Swiss 3T3 fibroblasts was enhanced in coculture with PLA2G3 tg/+ BMMCs relative to wild-type BMMCs (Supplementary Fig. 7i) . Thus, not only did mast cell-derived PLA2G3 supply arachidonic acid to L-PGDS in fibroblasts, it also contributed to induced expression of L-PGDS for efficient biosynthesis of a pool of PGD 2 that promotes maturation of mast cells. However, addition of PLA2G3 or BV-PLA 2 alone did not increase Ptgds expression in fibroblasts (Supplementary Fig. 7j ), suggesting that some additional mast cell-derived factor(s) may be required for the induction of L-PGDS in fibroblasts. In agreement with the in vitro studies, amounts of PGD 2 ( Fig. 6k) and expression of two PGDSs (Fig. 6l) 
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A r t i c l e s linked to fibroblastic L-PGDS-dependent synthesis of PGD 2 , which in turn activates DP1 induced on mast cells to assist their terminal maturation toward a fully anaphylaxis-sensitive CTMC-like phenotype (Supplementary Fig. 7k ).
PLA2G3 PGD 2 axis induces maturation of human mast cells
In human skin, toluidine blue + dermal mast cells showed PLA2G3 immunoreactivity, although some toluidine blue -cells also appeared PLA2G3 + (Fig. 7a) . We detected PLA2G3 mRNA expression in mast cells in preference to fibroblasts obtained from human lung and skin (Fig. 7b) . HDC mRNA expression was robustly induced in human lung mast cells after coculture with human lung fibroblasts, and this induction was suppressed either by anti-PLA2G3, by L-PGDS inhibitor (AT-56) or by DP1 antagonist (BW A868C) to a similar extent (Fig. 7c) . Thus, the fibroblast-dependent HDC induction in human mast cells also depends on the PLA2G3-L-PGDS-DP1 pathway.
DISCUSSION
Here we showed that PLA2G3, a major sPLA 2 in mast cells, contributed to anaphylaxis by inducing maturation of mast cells in concert with adjacent fibroblasts through a unique pathway involving a cell-to-cell loop of the biosynthetic and receptor pathway for PGD 2 . Promotion of mast cell maturation by PGD 2 -DP1 signaling provides a mechanistic explanation for the protective effect of systemic DP1 ablation on asthma 9 . The paracrine PGD 2 circuit driven by PLA2G3, an 'anaphylactic sPLA 2 ', is a previously unidentified lipid-orchestrated pathway linked to allergy and uncovers a missing microenvironmental cue underlying the proper maturation of mast cells.
The SCF-c-Kit system, in cooperation with transcription factors, integrins or accessory cytokines, is essential for the development, homing, proliferation and differentiation of mast cells [3] [4] [5] [6] [7] . However, SCF alone is insufficient to drive the full maturation of mast cells, leading to the hypothesis that some other stromal factor(s) may be additionally required. These signals may include, for instance, interleukin 33, nerve growth factor, the morphogen TGF-β, hyaluronic acid and the adhesion molecule SgIGSF (spermatogenic immunoglobulin superfamily) 3, 4, 7 , although their in vivo relevancies have not yet been fully understood. As in mice lacking PLA2G3, mast cells in mice lacking histamine (Hdc −/− ) or heparin (Ndst2 −/− or Srgn −/− ) are immature and have low histamine content [32] [33] [34] , suggesting that the lower amount of histamine may underlie, at least in part, the defective maturation of mast cells. We showed here that a signal driven by PGD 2 , a bioactive lipid, is a missing link required for the fibroblast-driven maturation of mast cells. The PLA2G3-L-PGDS-DP1 circuit revealed the paracrine action of sPLA 2 in the biosynthetic mobilization of PGD 2 by proximal cells, the functional segregation of the two PGDS enzymes in distinct cell populations and a new aspect of PGD 2 -DP1 signaling in promoting maturation of mast cells and thereby allergy. Moreover, our results revealed a previously unidentified aspect of the stromal cytokine SCF, which triggers this unique lipid-driven pathway by inducing PLA2G3 secretion from mast cells.
L-PGDS, a fibroblast-cell enzyme, acts downstream of PLA2G3 to supply PGD 2 to DP1 in mast cells to drive their terminal maturation. Contrary to our prediction, PGD 2 driven by H-PGDS, a mast cell enzyme, had an anti-allergy role, a view that is consistent with the exacerbated allergen-induced contact dermatitis in Ptgds2 −/− mice 11 . Although it is unclear how the L-PGDS-driven extrinsic, but not the H-PGDS-driven intrinsic, pool of PGD 2 is preferentially used by DP1 on mast cells, we speculate that the prolonged supply of PGD 2 by L-PGDS, rather than its transient supply by H-PGDS, may be suitable for a long-lasting cell differentiation process. Alternatively, the PGD 2 captured by L-PGDS, a lipid carrier protein (lipocalin), may be stabilized or better presented to mast cell DP1. This idea is reminiscent of a finding that lysophosphatidic acid (LPA), another lipid mediator, is presented to its cognate receptor as a complex with autotaxin, an LPA-producing enzyme 35 . The spatiotemporal discrimination of distinct PGD 2 pools is also supported by the fact that although PGD 2 promotes Th2-based asthma 9 , it contributes to resolution of inflammation through limiting neutrophil infiltration, dendritic cell activation or other mechanisms [11] [12] [13] .
The paracrine PLA2G3-L-PGDS-DP1 circuit could not be compensated by other PLA 2 enzymes, implying a specific role of this atypical sPLA 2 . We observed no defects in maturation of mast cells or anaphylaxis even in mice lacking cPLA 2 α, although mild developmental changes in Pla2g4a −/− BMMCs have been reported, probably because of different culture conditions 29 . Presumably, ablation of only the specific and local lipid mediator pathway by PLA2G3 deficiency, in contrast to ablation of bulk eicosanoids in both mast cells and microenvironments by cPLA 2 α deficiency 29 , may have a different impact on mast cells. The phenotypes observed in Pla2g3 −/− mice tend to be more severe than those observed in Ptgdr −/− or Ptgds −/− mice, suggesting that PLA2G3 might be also coupled with other lipid signal(s) that could act in concert with the L-PGDS-DP1 axis to promote full maturation of mast cells. Such lipid candidates include LPA and lysophosphatidylserine, which can affect mast cell development and activation 36, 37 . Not only can lysophospholipids transmit signals through their specific receptors, but they can also facilitate the opening of Ca 2+ channels, which might explain the degranulation-promoting effect of PLA2G3 on mast cells.
Although it has been proposed that sPLA 2 enzymes, after being secreted, may act on neighboring cells or extracellular phospholipids to augment lipid mediator biosynthesis, this idea has yet to gain traction because in vivo evidence is largely lacking. Our study provides to our knowledge the first clear in vivo evidence that sPLA 2 acts in this A r t i c l e s manner, thus providing a rationale for the long-standing question on the role of the secreted type of PLA 2 . This extracellular PLA 2 family, through a paracrine process, regulates homeostasis and pathology in response to a given microenvironmental cue. Given that PLA2G3 is insensitive to classical sPLA 2 inhibitors, a new agent that specifically inhibits this unique sPLA 2 may be useful for the treatment of patients with mast cell-associated allergic and other diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
